captopril has been researched along with benazepril in 33 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 5 (15.15) | 18.7374 |
| 1990's | 12 (36.36) | 18.2507 |
| 2000's | 8 (24.24) | 29.6817 |
| 2010's | 8 (24.24) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Babiarz, JE; Desai, MN; Finn, BM; Stanton, JL; Tomaselli, HC; Watthey, JW | 1 |
| Carlson, JE; Chatelain, R; Fink, CA; Jeng, AY; McTaggart, PA; Qiao, Y; Trapani, AJ; Webb, R | 1 |
| Abbenante, G; Fairlie, DP; Leung, D | 1 |
| Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL | 1 |
| Fisk, L; Greene, N; Naven, RT; Note, RR; Patel, ML; Pelletier, DJ | 1 |
| Ekins, S; Williams, AJ; Xu, JJ | 1 |
| Bellera, CL; Bruno-Blanch, LE; Castro, EA; Duchowicz, PR; Goodarzi, M; Ortiz, EV; Pesce, G; Talevi, A | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Imai, S; Ishibashi, T; Mitomi, A; Tanaka, M; Tatebe, S | 1 |
| Inukai, T; Katsumura, H; Nakao, K; Ogawa, N; Ohara, N; Ono, H; Shukunobe, K; Tanaka, M; Yamamoto, S | 1 |
| Boland, MJ; Cinquegrani, MP; Insel, J; Mirvis, DM; Rubin, SA; Shanes, J; Whalen, JJ | 1 |
| Brunner, HR; Nussberger, J; Waeber, B | 1 |
| Giannattasio, C; Grassi, G; Mancia, G; Morganti, A; Seravalle, G; Zanchetti, A | 1 |
| Dandona, P; Jeremy, JY; Mikhailidis, DP | 1 |
| Chang, MS; Chen, CH; Chou, P; Hsu, TL; Lin, SJ; Ting, CT; Wang, SP; Yin, FC | 1 |
| Fogari, R; Lusardi, P; Motolese, M; Tettamanti, F; Tettamanzi, D; Zoppi, A | 1 |
| Bolshakova, TD; Golubev, SA; Olbinskaya, LI | 1 |
| Almeida, FA; Carvalho, JG; Mansur, Ade P; Ramires, JA | 1 |
| Golubev, SA; Morozova, TE; Ol'binskaia, LI | 1 |
| Peczkowska, M | 1 |
| Dachman, W; Székács, B; Vajo, Z | 1 |
| Hamlin, R; Mandigers, PJ; Pijpers, FS | 1 |
| Bombin, C; Figueredo, E; Lluch-Bernal, M; Novalbos, A; Sastre, J; Umpierrez, A | 1 |
| Fujisawa, K; Hiraoka, M; Hori, C; Mayumi, M; Ohshima, Y; Tsukahara, H; Tsuzuki, K; Yoshida, Y; Yoshikawa, N; Yoshioka, K | 1 |
| Bertocchi, F; Carretta, R; Di Somma, S; Malacco, E; Mugellini, A; Palatini, P; Piazza, S | 1 |
| Bicket, DP | 1 |
| Li, VV; Suvorova, SS; Timofeeva, NIu; Zadionchenko, VS | 1 |
| Pfützner, W; Przybilla, B; Ruëff, F | 1 |
| Geng, QX; Luo, J; Ma, XJ; Shao, JH; Tang, YS; Xu, FY; Zhang, XH; Zhu, XL | 1 |
| Chou, J; Debanne, SM; Fang, JC; Mishra, P; Simon, DI; Sipahi, I | 1 |
| Shen, S; Shi, Y; Yang, X | 1 |
| Mahrouse, MA | 1 |
| Habara, M; Haraguchi, T; Ikezaki, H; Kojima, H; Nakamura, S; Uchida, T; Yoshida, M | 1 |
5 review(s) available for captopril and benazepril
| Article | Year |
|---|---|
Protease inhibitors: current status and future prospects.
Topics: Animals; Aspartic Acid Endopeptidases; Cysteine Endopeptidases; Cysteine Proteinase Inhibitors; Humans; Metalloendopeptidases; Models, Molecular; Protease Inhibitors; Serine Endopeptidases; Serine Proteinase Inhibitors | 2000 |
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
The present molecules of converting enzyme inhibitors.
Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Benzazepines; Blood Pressure; Bridged Bicyclo Compounds; Captopril; Cilazapril; Cyclopentanes; Dipeptides; Enalapril; Humans; Indoles; Lisinopril; Perindopril; Pyridazines; Ramipril; Renin-Angiotensin System | 1985 |
Using ACE inhibitors appropriately.
Topics: Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Benzazepines; Captopril; Cardiovascular Diseases; Clinical Trials as Topic; Contraindications; Diabetic Nephropathies; Drug Costs; Enalapril; Fosinopril; Heart Failure; Humans; Hypertension; Indoles; Isoquinolines; Lisinopril; Meta-Analysis as Topic; Myocardial Infarction; Perindopril; Quinapril; Ramipril; Renin-Angiotensin System; Risk; Tetrahydroisoquinolines; United States | 2002 |
Meta-analysis of randomized controlled trials on effect of angiotensin-converting enzyme inhibitors on cancer risk.
Topics: Angiotensin-Converting Enzyme Inhibitors; Benzazepines; Captopril; Enalapril; Fosinopril; Humans; Lisinopril; Neoplasms; Quinapril; Ramipril; Randomized Controlled Trials as Topic; Tetrahydroisoquinolines | 2011 |
10 trial(s) available for captopril and benazepril
| Article | Year |
|---|---|
A multicenter study of the safety and efficacy of benazepril hydrochloride, a long-acting angiotensin-converting enzyme inhibitor, in patients with chronic congestive heart failure.
Topics: Adult; Aged; Aldosterone; Angiotensin-Converting Enzyme Inhibitors; Benzazepines; Captopril; Chronic Disease; Enalapril; Female; Heart Failure; Hemodynamics; Humans; Male; Middle Aged; Multicenter Studies as Topic; Peptidyl-Dipeptidase A; Renin; Time Factors | 1989 |
Short-term and long-term effects of benazepril in mild to moderate hypertensives.
Topics: Adult; Aged; Aged, 80 and over; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Benzazepines; Captopril; Double-Blind Method; Female; Humans; Hypertension; Male; Middle Aged; Time Factors | 1995 |
Evaluation by 24-hour ambulatory blood pressure monitoring of efficacy of benazepril 20 mg plus hydrochlorothiazide 25 mg fixed combination as compared to captopril 50 mg [corrected] plus hydrochlorothiazide 25 mg fixed combination in treating mild to mod
Topics: Administration, Oral; Adult; Analysis of Variance; Antihypertensive Agents; Benzazepines; Blood Pressure; Blood Pressure Monitoring, Ambulatory; Captopril; Cross-Over Studies; Double-Blind Method; Drug Therapy, Combination; Female; Heart Rate; Humans; Hydrochlorothiazide; Hypertension; Male; Middle Aged; Outpatients | 1994 |
Influence of benazepril and captopril on blood pressure, glucocorticoids and progesterone in essential hypertensives.
Topics: Angiotensin-Converting Enzyme Inhibitors; Benzazepines; Blood Pressure; Captopril; Female; Glucocorticoids; Humans; Hypertension; Male; Middle Aged; Progesterone | 1993 |
[Multicenter comparative study of the effects of benazepril and captopril in mild and moderate systemic hypertension].
Topics: Adult; Aged; Benzazepines; Captopril; Double-Blind Method; Female; Humans; Hypertension; Male; Middle Aged | 1993 |
[Effectiveness and tolerance of benazepril versus captopril in patients with hypertension].
Topics: Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Benzazepines; Blood Pressure; Captopril; Data Interpretation, Statistical; Double-Blind Method; Drug Tolerance; Female; Heart Rate; Humans; Hypertension; Male; Middle Aged; Models, Theoretical; Time Factors | 1995 |
[Influence of angiotensin I converting enzyme inhibitors on selected parameters of zinc metabolism].
Topics: Adult; Angiotensin-Converting Enzyme Inhibitors; Benzazepines; Captopril; Double-Blind Method; Drug Administration Schedule; Female; Humans; Hypertension; Male; Middle Aged; Zinc | 1996 |
Effect of ACE inhibition by benazepril, enalapril and captopril on chronic and post exercise proteinuria.
Topics: Adult; Angiotensin-Converting Enzyme Inhibitors; Benzazepines; Captopril; Chronic Disease; Diabetes Mellitus, Type 2; Enalapril; Exercise; Female; Glomerulonephritis; Humans; Male; Proteinuria | 1996 |
Comparison of benazepril-amlodipine and captopril-thiazide combinations in the management of mild-to-moderate hypertension.
Topics: Administration, Oral; Aged; Amlodipine; Antihypertensive Agents; Benzazepines; Captopril; Double-Blind Method; Drug Administration Schedule; Drug Therapy, Combination; Female; Humans; Hydrochlorothiazide; Hypertension; Male; Middle Aged | 2002 |
[Comparative effectiveness of lotensin and capoten in patients with chronic cardiac failure].
Topics: Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Benzazepines; Captopril; Exercise; Heart Failure; Humans; Platelet Aggregation; Treatment Outcome | 2003 |
18 other study(ies) available for captopril and benazepril
| Article | Year |
|---|---|
Angiotensin converting enzyme inhibitors: structure-activity profile of 1-benzazepin-2-one derivatives.
Topics: Amino Acids; Angiotensin-Converting Enzyme Inhibitors; Animals; Benzazepines; Blood Pressure; Chemical Phenomena; Chemistry; Dogs; Hypertension; Rats; Rats, Inbred SHR; Structure-Activity Relationship | 1985 |
Mercaptoacyl dipeptides as orally active dual inhibitors of angiotensin-converting enzyme and neutral endopeptidase.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Atrial Natriuretic Factor; Benzazepines; Blood Pressure; Captopril; Dipeptides; Magnetic Resonance Spectroscopy; Male; Molecular Structure; Neprilysin; Protease Inhibitors; Rats; Rats, Inbred SHR; Tyrosine | 1996 |
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration | 2004 |
Developing structure-activity relationships for the prediction of hepatotoxicity.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Humans; Structure-Activity Relationship; Tetracyclines; Thiophenes | 2010 |
A predictive ligand-based Bayesian model for human drug-induced liver injury.
Topics: Bayes Theorem; Chemical and Drug Induced Liver Injury; Humans; Ligands | 2010 |
Prediction of drug intestinal absorption by new linear and non-linear QSPR.
Topics: Humans; Intestinal Absorption; Linear Models; Molecular Conformation; Nonlinear Dynamics; Permeability; Pharmaceutical Preparations; Probability; Quantitative Structure-Activity Relationship; Thermodynamics | 2011 |
Hemodynamic effects of benazepril, an angiotensin-converting enzyme inhibitor, as studied in conscious normotensive dogs.
Topics: Angiotensin I; Angiotensin-Converting Enzyme Inhibitors; Animals; Benzazepines; Captopril; Dogs; Hemodynamics; Male; Peptidyl-Dipeptidase A | 1991 |
Antihypertensive action of the novel angiotensin converting enzyme inhibitor benazepril hydrochloride in hypertensive rat models.
Topics: Administration, Oral; Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Benzazepines; Captopril; Desoxycorticosterone; Enalapril; Hypertension; Hypertension, Renovascular; Male; Rats; Rats, Inbred SHR; Rats, Inbred Strains | 1991 |
Investigation of reflexes from volume and baroreceptors during converting-enzyme inhibition in humans.
Topics: Angiotensin-Converting Enzyme Inhibitors; Benzazepines; Blood Pressure; Blood Volume; Captopril; Humans; Hypertension; Pressoreceptors; Reflex; Renin-Angiotensin System; Sympathetic Nervous System; Vascular Resistance; Vasodilation | 1989 |
Angiotensin converting enzyme inhibitors (captopril, CGS14831 and CGS14824A) antagonise in vitro smooth muscle prostanoid synthesis: evidence for calcium channel blockade.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Arachidonic Acid; Arachidonic Acids; Benzazepines; Calcimycin; Calcium Channel Blockers; Captopril; Carbachol; Epinephrine; Epoprostenol; In Vitro Techniques; Male; Muscle, Smooth; Muscle, Smooth, Vascular; Rats; Rats, Inbred Strains; Urinary Bladder; Wounds and Injuries | 1988 |
Plasma ACE inhibition by five different ACE inhibitors.
Topics: Administration, Oral; Angiotensin-Converting Enzyme Inhibitors; Animals; Benzazepines; Captopril; Dogs; Enalapril; Lisinopril; Peptidyl-Dipeptidase A; Ramipril | 1998 |
Cutaneous reaction to captopril with positive patch test and lack of cross-sensitivity to enalapril and benazepril.
Topics: Administration, Oral; Angiotensin-Converting Enzyme Inhibitors; Benzazepines; Captopril; Cross Reactions; Double-Blind Method; Drug Eruptions; Enalapril; Facial Dermatoses; Humans; Hypertension; Male; Middle Aged; Patch Tests | 1998 |
Significance of ACE genotypes and medical treatments in childhood focal glomerulosclerosis.
Topics: Angiotensin-Converting Enzyme Inhibitors; Anti-Inflammatory Agents; Benzazepines; Captopril; Child; Disease Progression; Drug Resistance; Enalapril; Female; Glomerulosclerosis, Focal Segmental; Humans; Incidence; Japan; Kidney Failure, Chronic; Male; Peptidyl-Dipeptidase A; Prednisolone; Proteinuria; Regression Analysis; Retrospective Studies; Survival Rate | 2001 |
Systemic contact dermatitis due to captopril without cross-sensitivity to fosinopril, quinapril and benazepril.
Topics: Administration, Oral; Aged; Angiotensin-Converting Enzyme Inhibitors; Benzazepines; Captopril; Dermatitis, Contact; Female; Fosinopril; Humans; Hypertension; Quinapril; Skin Tests; Tetrahydroisoquinolines | 2004 |
[Effect of different angiotensin converting enzyme inhibitors on coronary collateral circulation].
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Benzazepines; Captopril; Collateral Circulation; Coronary Circulation; Dogs; Female; Male; Peptidyl-Dipeptidase A; Random Allocation; Spectrometry, Fluorescence | 2004 |
Application of quantitative NMR for purity determination of standard ACE inhibitors.
Topics: Angiotensin-Converting Enzyme Inhibitors; Benzazepines; Calibration; Captopril; Carbon; Deuterium Oxide; Enalapril; Enzyme Inhibitors; Hydrogen-Ion Concentration; Imidazolidines; Lisinopril; Magnetic Resonance Spectroscopy; Maleates; Methanol; Quinapril; Reference Standards; Solvents; Stereoisomerism; Tetrahydroisoquinolines | 2015 |
Simultaneous ultraperformance liquid chromatography/tandem mass spectrometry determination of four antihypertensive drugs in human plasma using hydrophilic-lipophilic balanced reversed-phase sorbents sample preparation protocol.
Topics: Antihypertensive Agents; Benzazepines; Captopril; Chromatography, High Pressure Liquid; Chromatography, Reverse-Phase; Fosinopril; Humans; Hydrochlorothiazide; Hydrophobic and Hydrophilic Interactions; Limit of Detection; Linear Models; Reproducibility of Results; Solid Phase Extraction; Tandem Mass Spectrometry | 2018 |
A new strategy for taste masking on bitter drug by other combined drug in fixed-dose combination: bitterness of Amlodipine besylate could be masked efficiently by Valsartan.
Topics: Amlodipine; Benzazepines; Captopril; Dose-Response Relationship, Drug; Humans; Hydrochlorothiazide; Taste; Taste Perception; Telmisartan; Valsartan | 2019 |